Cargando…
DNA methylation markers for oral pre-cancer progression: A critical review
Although oral cancers are generally preceded by a well-established pre-cancerous stage, there is a lack of well-defined clinical and morphological criteria to detect and signal progression from pre-cancer to malignant tumours. We conducted a critical review to summarize the evidence regarding aberra...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788701/ https://www.ncbi.nlm.nih.gov/pubmed/26690652 http://dx.doi.org/10.1016/j.oraloncology.2015.11.012 |
_version_ | 1782420755490799616 |
---|---|
author | Shridhar, Krithiga Walia, Gagandeep Kaur Aggarwal, Aastha Gulati, Smriti Geetha, A.V. Prabhakaran, Dorairaj Dhillon, Preet K. Rajaraman, Preetha |
author_facet | Shridhar, Krithiga Walia, Gagandeep Kaur Aggarwal, Aastha Gulati, Smriti Geetha, A.V. Prabhakaran, Dorairaj Dhillon, Preet K. Rajaraman, Preetha |
author_sort | Shridhar, Krithiga |
collection | PubMed |
description | Although oral cancers are generally preceded by a well-established pre-cancerous stage, there is a lack of well-defined clinical and morphological criteria to detect and signal progression from pre-cancer to malignant tumours. We conducted a critical review to summarize the evidence regarding aberrant DNA methylation patterns as a potential diagnostic biomarker predicting progression. We identified all relevant human studies published in English prior to 30th April 2015 that examined DNA methylation (%) in oral pre-cancer by searching PubMed, Web-of-Science and Embase databases using combined key-searches. Twenty-one studies (18-cross-sectional; 3-longitudinal) were eligible for inclusion in the review, with sample sizes ranging from 4 to 156 affected cases. Eligible studies examined promoter region hyper-methylation of tumour suppressor genes in pathways including cell-cycle-control (n = 15), DNA-repair (n = 7), cell-cycle-signalling (n = 4) and apoptosis (n = 3). Hyper-methylated loci reported in three or more studies included p16, p14, MGMT and DAPK. Two longitudinal studies reported greater p16 hyper-methylation in pre-cancerous lesions transformed to malignancy compared to lesions that regressed (57–63.6% versus 8–32.1%; p < 0.01). The one study that explored epigenome-wide methylation patterns reported three novel hyper-methylated loci (TRHDE; ZNF454; KCNAB3). The majority of reviewed studies were small, cross-sectional studies with poorly defined control groups and lacking validation. Whilst limitations in sample size and study design preclude definitive conclusions, current evidence suggests a potential utility of DNA methylation patterns as a diagnostic biomarker for oral pre-cancer progression. Robust studies such as large epigenome-wide methylation explorations of oral pre-cancer with longitudinal tracking are needed to validate the currently reported signals and identify new risk-loci and the biological pathways of disease progression. |
format | Online Article Text |
id | pubmed-4788701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-47887012016-03-22 DNA methylation markers for oral pre-cancer progression: A critical review Shridhar, Krithiga Walia, Gagandeep Kaur Aggarwal, Aastha Gulati, Smriti Geetha, A.V. Prabhakaran, Dorairaj Dhillon, Preet K. Rajaraman, Preetha Oral Oncol Review Although oral cancers are generally preceded by a well-established pre-cancerous stage, there is a lack of well-defined clinical and morphological criteria to detect and signal progression from pre-cancer to malignant tumours. We conducted a critical review to summarize the evidence regarding aberrant DNA methylation patterns as a potential diagnostic biomarker predicting progression. We identified all relevant human studies published in English prior to 30th April 2015 that examined DNA methylation (%) in oral pre-cancer by searching PubMed, Web-of-Science and Embase databases using combined key-searches. Twenty-one studies (18-cross-sectional; 3-longitudinal) were eligible for inclusion in the review, with sample sizes ranging from 4 to 156 affected cases. Eligible studies examined promoter region hyper-methylation of tumour suppressor genes in pathways including cell-cycle-control (n = 15), DNA-repair (n = 7), cell-cycle-signalling (n = 4) and apoptosis (n = 3). Hyper-methylated loci reported in three or more studies included p16, p14, MGMT and DAPK. Two longitudinal studies reported greater p16 hyper-methylation in pre-cancerous lesions transformed to malignancy compared to lesions that regressed (57–63.6% versus 8–32.1%; p < 0.01). The one study that explored epigenome-wide methylation patterns reported three novel hyper-methylated loci (TRHDE; ZNF454; KCNAB3). The majority of reviewed studies were small, cross-sectional studies with poorly defined control groups and lacking validation. Whilst limitations in sample size and study design preclude definitive conclusions, current evidence suggests a potential utility of DNA methylation patterns as a diagnostic biomarker for oral pre-cancer progression. Robust studies such as large epigenome-wide methylation explorations of oral pre-cancer with longitudinal tracking are needed to validate the currently reported signals and identify new risk-loci and the biological pathways of disease progression. Elsevier 2016-02 /pmc/articles/PMC4788701/ /pubmed/26690652 http://dx.doi.org/10.1016/j.oraloncology.2015.11.012 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Shridhar, Krithiga Walia, Gagandeep Kaur Aggarwal, Aastha Gulati, Smriti Geetha, A.V. Prabhakaran, Dorairaj Dhillon, Preet K. Rajaraman, Preetha DNA methylation markers for oral pre-cancer progression: A critical review |
title | DNA methylation markers for oral pre-cancer progression: A critical review |
title_full | DNA methylation markers for oral pre-cancer progression: A critical review |
title_fullStr | DNA methylation markers for oral pre-cancer progression: A critical review |
title_full_unstemmed | DNA methylation markers for oral pre-cancer progression: A critical review |
title_short | DNA methylation markers for oral pre-cancer progression: A critical review |
title_sort | dna methylation markers for oral pre-cancer progression: a critical review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788701/ https://www.ncbi.nlm.nih.gov/pubmed/26690652 http://dx.doi.org/10.1016/j.oraloncology.2015.11.012 |
work_keys_str_mv | AT shridharkrithiga dnamethylationmarkersfororalprecancerprogressionacriticalreview AT waliagagandeepkaur dnamethylationmarkersfororalprecancerprogressionacriticalreview AT aggarwalaastha dnamethylationmarkersfororalprecancerprogressionacriticalreview AT gulatismriti dnamethylationmarkersfororalprecancerprogressionacriticalreview AT geethaav dnamethylationmarkersfororalprecancerprogressionacriticalreview AT prabhakarandorairaj dnamethylationmarkersfororalprecancerprogressionacriticalreview AT dhillonpreetk dnamethylationmarkersfororalprecancerprogressionacriticalreview AT rajaramanpreetha dnamethylationmarkersfororalprecancerprogressionacriticalreview |